-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $205

Benzinga·04/28/2025 13:57:37
Listen to the news
Evercore ISI Group analyst Gavin Clark-Gartner maintains AbbVie (NYSE:ABBV) with a Outperform and raises the price target from $204 to $205.